Management of complex OAB patients: A call to action

Ekene Enemchukwu; Anne Cameron

doi:10.1002/nau.25048

Management of complex OAB patients: A call to action

Neurourol Urodyn. 2022 Nov;41(8):1938-1939. doi: 10.1002/nau.25048. Epub 2022 Sep 18.

Authors

Ekene Enemchukwu¹, Anne Cameron²

Affiliations

¹ Department of Urology, Stanford University School of Medicine, Paolo Alto, California, USA.
² Department of Urology, University of Michigan, Ann Arbor, Michigan, USA.

PMID: 36116063
DOI: 10.1002/nau.25048

No abstract available

Keywords: benign prostatic hypertrophy; botulinum toxin; health disparities; neuromodulation; overactive bladder; painful bladder syndrome; urgency incontinence.

Publication types

Editorial

MeSH terms

Botulinum Toxins, Type A*
Humans
Urinary Bladder, Overactive* / therapy

Substances

Botulinum Toxins, Type A